I
ADMA icon

InceptionR’s ADMA Biologics ADMA Stock Holding History

InceptionR’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193K Buy
+21,472
New +$339K 0.05% 592
2025
Q2 		– Sell
-15,100
Closed -$300K – 635
2025
Q1 		$300K Sell
15,100
-11,278
-43% -$195K 0.09% 382
2024
Q4 		$452K Buy
+26,378
New +$496K 0.1% 357

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

InceptionR's ADMA Position: Q1 2026 in Review

InceptionR opened a new position in ADMA Biologics (ADMA) in Q1 2026: 21,472 shares worth $193K. The stake represents 0.05% of the portfolio and ranks #592 among its holdings. This is a return to the name: InceptionR previously reported a position in ADMA as recently as Q1 2025.

InceptionR first reported a position in ADMA in Q4 2024 and has held it in 3 quarters since. The position peaked at $452K in Q4 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • InceptionR held 21,472 shares of ADMA Biologics worth $193K as of Q1 2026.
  • ADMA Biologics was a new InceptionR position in Q1 2026.
  • ADMA Biologics made up 0.05% of InceptionR's portfolio in Q1 2026, its #592 holding.
  • InceptionR first reported a position in ADMA Biologics in Q4 2024 and has held it in 3 quarters since.
  • InceptionR's ADMA Biologics position peaked at $452K in Q4 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.